ONCY logo

Oncolytics Biotech (ONCY) Cash From Financing

Annual CFF

$23.69 M
+$14.31 M+152.58%

December 31, 2023


Summary


Performance

ONCY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherONCYcash flowmetrics:

Quarterly CFF

N/A

September 30, 2024


Summary


Performance

ONCY Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCYcash flowmetrics:

TTM CFF

N/A

September 30, 2024


Summary


Performance

ONCY TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherONCYcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ONCY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+152.6%--
3 y3 years-20.2%--
5 y5 years+130.9%--

ONCY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.0%+152.6%
5 y5-year-20.2%+152.6%
alltimeall time-27.4%>+9999.0%

Oncolytics Biotech Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2023
$23.69 M(+152.6%)
$1.15 M(-92.7%)
$23.69 M(-12.5%)
Sep 2023
-
$15.88 M(+473.8%)
$27.07 M(+125.6%)
Jun 2023
-
$2.77 M(-29.0%)
$12.00 M(+28.7%)
Mar 2023
-
$3.90 M(-14.0%)
$9.32 M(-0.6%)
Dec 2022
$9.38 M(-64.4%)
$4.53 M(+462.2%)
$9.38 M(+90.3%)
Sep 2022
-
$805.70 K(+799.2%)
$4.93 M(+45.5%)
Jun 2022
-
$89.60 K(-97.7%)
$3.39 M(-67.5%)
Mar 2022
-
$3.96 M(+4895.3%)
$10.43 M(-60.4%)
Dec 2021
$26.33 M(-11.3%)
$79.20 K(-110.8%)
$26.33 M(-24.1%)
Sep 2021
-
-$736.10 K(-110.3%)
$34.68 M(-10.5%)
Jun 2021
-
$7.13 M(-64.1%)
$38.75 M(+7.8%)
Mar 2021
-
$19.86 M(+135.7%)
$35.94 M(+21.1%)
Dec 2020
$29.68 M(+87.5%)
$8.42 M(+152.7%)
$29.68 M(+4.8%)
Sep 2020
-
$3.33 M(-22.9%)
$28.33 M(-0.4%)
Jun 2020
-
$4.32 M(-68.2%)
$28.44 M(+7.8%)
Mar 2020
-
$13.61 M(+92.4%)
$26.37 M(+66.6%)
Dec 2019
$15.83 M(+54.3%)
$7.07 M(+105.8%)
$15.83 M(+60.4%)
Sep 2019
-
$3.44 M(+52.1%)
$9.87 M(+35.8%)
Jun 2019
-
$2.26 M(-26.3%)
$7.27 M(-43.7%)
Mar 2019
-
$3.07 M(+176.2%)
$12.92 M(+25.9%)
Dec 2018
$10.26 M(+3.8%)
$1.11 M(+33.0%)
$10.26 M(+8.4%)
Sep 2018
-
$834.30 K(-89.4%)
$9.46 M(-4.1%)
Jun 2018
-
$7.91 M(+1819.0%)
$9.86 M(-4.3%)
Mar 2018
-
$412.00 K(+32.3%)
$10.31 M(+4.2%)
Dec 2017
$9.89 M(+1269.3%)
$311.50 K(-74.8%)
$9.89 M(+2.5%)
Sep 2017
-
$1.23 M(-85.2%)
$9.64 M(+12.3%)
Jun 2017
-
$8.35 M(<-9900.0%)
$8.59 M(+991.0%)
Mar 2017
-
-$7900.00(-111.6%)
$787.30 K(+9.1%)
Dec 2016
$722.00 K(-96.1%)
$68.30 K(-62.1%)
$721.90 K(-38.9%)
Sep 2016
-
$180.40 K(-67.0%)
$1.18 M(+5927.6%)
Jun 2016
-
$546.50 K(-845.6%)
$19.60 K(-99.6%)
Mar 2016
-
-$73.30 K(-113.9%)
$5.09 M(-72.5%)
Dec 2015
$18.54 M(+126.3%)
$527.80 K(-153.8%)
$18.54 M(-8.7%)
Sep 2015
-
-$981.40 K(-117.5%)
$20.30 M(-14.7%)
Jun 2015
-
$5.62 M(-58.0%)
$23.81 M(+16.2%)
Mar 2015
-
$13.38 M(+484.4%)
$20.49 M(+150.1%)
Dec 2014
$8.19 M(-72.2%)
$2.29 M(-9.2%)
$8.19 M(+31.4%)
Sep 2014
-
$2.52 M(+9.3%)
$6.23 M(+90.9%)
Jun 2014
-
$2.31 M(+113.8%)
$3.26 M(+533.1%)
Mar 2014
-
$1.08 M(+226.8%)
$515.70 K(-98.3%)
Dec 2013
$29.52 M(+41.6%)
$329.90 K(-173.6%)
$29.52 M(+1.1%)
Sep 2013
-
-$448.50 K(+1.1%)
$29.21 M(-2.8%)
Jun 2013
-
-$443.80 K(-101.5%)
$30.05 M(-2.2%)
Mar 2013
-
$30.08 M(>+9900.0%)
$30.71 M(+47.3%)
Dec 2012
$20.85 M(+39.1%)
$19.40 K(-95.0%)
$20.85 M(+0.7%)
Sep 2012
-
$388.80 K(+74.5%)
$20.72 M(+2.5%)
Jun 2012
-
$222.80 K(-98.9%)
$20.21 M(-0.4%)
Mar 2012
-
$20.22 M(<-9900.0%)
$20.29 M(+35.4%)
DateAnnualQuarterlyTTM
Dec 2011
$14.99 M(-43.3%)
-$115.90 K(-2.7%)
$14.99 M(-63.9%)
Sep 2011
-
-$119.10 K(-138.9%)
$41.51 M(-0.3%)
Jun 2011
-
$305.80 K(-98.0%)
$41.63 M(+0.6%)
Mar 2011
-
$14.92 M(-43.5%)
$41.38 M(+56.4%)
Dec 2010
$26.46 M(-18.9%)
$26.40 M(>+9900.0%)
$26.46 M(+6.6%)
Sep 2010
-
$8000.00(-84.8%)
$24.82 M(-2.7%)
Jun 2010
-
$52.50 K(>+9900.0%)
$25.50 M(-21.8%)
Mar 2010
-
$0.00(-100.0%)
$32.60 M(-0.1%)
Dec 2009
$32.62 M(+900.2%)
$24.75 M(+3462.9%)
$32.62 M(+193.2%)
Sep 2009
-
$694.80 K(-90.3%)
$11.13 M(+6.7%)
Jun 2009
-
$7.15 M(>+9900.0%)
$10.43 M(+218.2%)
Mar 2009
-
$17.10 K(-99.5%)
$3.28 M(+0.5%)
Dec 2008
$3.26 M(-71.2%)
$3.26 M(>+9900.0%)
$3.26 M(-1647.1%)
Sep 2008
-
$0.00(0.0%)
-$210.80 K(-162.3%)
Jun 2008
-
$0.00(0.0%)
$338.20 K(-67.2%)
Mar 2008
-
$0.00(-100.0%)
$1.03 M(-90.9%)
Dec 2007
$11.33 M(+5224.5%)
-$210.80 K(-138.4%)
$11.33 M(-2.7%)
Sep 2007
-
$549.00 K(-20.8%)
$11.64 M(+4.2%)
Jun 2007
-
$693.30 K(-93.3%)
$11.17 M(+6.2%)
Mar 2007
-
$10.30 M(>+9900.0%)
$10.51 M(+4839.8%)
Dec 2006
$212.80 K(-98.6%)
$99.10 K(+30.7%)
$212.80 K(-98.3%)
Sep 2006
-
$75.80 K(+100.0%)
$12.81 M(-0.6%)
Jun 2006
-
$37.90 K(>+9900.0%)
$12.89 M(-0.9%)
Mar 2006
-
$0.00(-100.0%)
$13.00 M(-16.2%)
Dec 2005
$15.51 M(-14.3%)
$12.69 M(+7963.2%)
$15.51 M(+49.7%)
Sep 2005
-
$157.40 K(+5.9%)
$10.36 M(-21.5%)
Jun 2005
-
$148.60 K(-94.1%)
$13.20 M(-33.6%)
Mar 2005
-
$2.51 M(-66.7%)
$19.88 M(+9.9%)
Dec 2004
$18.09 M(+58.0%)
$7.54 M(+151.7%)
$18.09 M(+24.4%)
Sep 2004
-
$3.00 M(-56.1%)
$14.54 M(+0.8%)
Jun 2004
-
$6.83 M(+852.9%)
$14.42 M(+20.1%)
Mar 2004
-
$716.90 K(-82.0%)
$12.01 M(+4.8%)
Dec 2003
$11.45 M(+896.2%)
$3.99 M(+38.6%)
$11.45 M(+33.4%)
Sep 2003
-
$2.88 M(-34.8%)
$8.59 M(+49.9%)
Jun 2003
-
$4.42 M(+2633.5%)
$5.73 M(+336.9%)
Mar 2003
-
$161.60 K(-85.7%)
$1.31 M(+14.1%)
Dec 2002
$1.15 M(-19.5%)
$1.13 M(+5072.5%)
$1.15 M(+219.0%)
Sep 2002
-
$21.80 K(>+9900.0%)
$360.30 K(-44.4%)
Jun 2002
-
$0.00(0.0%)
$648.10 K(-39.5%)
Mar 2002
-
$0.00(-100.0%)
$1.07 M(-25.0%)
Dec 2001
$1.43 M(-87.2%)
$338.50 K(+9.3%)
$1.43 M(+26.2%)
Sep 2001
-
$309.60 K(-26.8%)
$1.13 M(-61.6%)
Jun 2001
-
$423.20 K(+18.8%)
$2.94 M(+25.4%)
Mar 2001
-
$356.20 K(+752.2%)
$2.35 M(-79.0%)
Dec 2000
$11.18 M(+222.4%)
$41.80 K(-98.0%)
$11.18 M(+0.4%)
Sep 2000
-
$2.12 M(-1327.0%)
$11.14 M(+23.5%)
Jun 2000
-
-$172.80 K(-101.9%)
$9.02 M(-1.9%)
Mar 2000
-
$9.19 M
$9.19 M
Dec 1999
$3.47 M
-
-

FAQ

  • What is Oncolytics Biotech annual cash flow from financing activities?
  • What is the all time high annual CFF for Oncolytics Biotech?
  • What is Oncolytics Biotech annual CFF year-on-year change?
  • What is the all time high quarterly CFF for Oncolytics Biotech?
  • What is the all time high TTM CFF for Oncolytics Biotech?

What is Oncolytics Biotech annual cash flow from financing activities?

The current annual CFF of ONCY is $23.69 M

What is the all time high annual CFF for Oncolytics Biotech?

Oncolytics Biotech all-time high annual cash flow from financing activities is $32.62 M

What is Oncolytics Biotech annual CFF year-on-year change?

Over the past year, ONCY annual cash flow from financing activities has changed by +$14.31 M (+152.58%)

What is the all time high quarterly CFF for Oncolytics Biotech?

Oncolytics Biotech all-time high quarterly cash flow from financing activities is $30.08 M

What is the all time high TTM CFF for Oncolytics Biotech?

Oncolytics Biotech all-time high TTM cash flow from financing activities is $41.63 M